Circulating levels of these apolipoproteins with characteristic MPO-modified amino acids such as carbamyllysine, 3-chlorotyrosine, 3-nitrotyrosine, and oxidized tryptophan are elevated in CAD patients, and correlate with disease severity and risk [77,78,79]. The gene discussed is MPO; the disease is coronary artery disorder.